Long-term safety in patients with recurrent ovarian cancer treated with niraparib versus placebo: Results from the phase III ENGOT-OV16/NOVA trial by Mirza, Mansoor R., Benigno, B., Dørum, A., Mahner, S., Bessette, P., Barceló, I. Bover, Berton-Rigaud, D., Ledermann, J.A., Rimel, B.J., Herrstedt, J., Lau, S., du Bois, A., Herráez, A. Casado, Kalbacher, E., Buscema, J., Lorusso, D., Vergote, I., Levy, T., Wang, P., de Jong, F.A., Gupta, D., Matulonis, U.A.

Get full text

SEOM Clinical Guideline of management of soft-tissue sarcoma (2020) by de Juan Ferré, A., Álvarez Álvarez, R., Casado Herráez, A., Cruz Jurado, J., Estival González, A., Martín-Broto, J., Martínez Marín, V., Moreno Vega, A., Sebio García, A., Valverde Morales, C.

Get full text

Maintenance therapy of patients with recurrent epithelial ovarian carcinoma with the anti-tumor-associated-mucin-1 antibody gatipotuzumab: results from a double-blind, placebo-cont... by Ledermann, J.A., Zurawski, B., Raspagliesi, F., De Giorgi, U., Arranz Arija, J., Romeo Marin, M., Lisyanskaya, A., Póka, R.L., Markowska, J., Cebotaru, C., Casado Herraez, A., Colombo, N., Kutarska, E., Hall, M., Jacobs, A., Ahrens-Fath, I., Baumeister, H., Zurlo, A., Sehouli, J.

Get full text

Randomized study of sequential cisplatin-topotecan/carboplatin-paclitaxel versus carboplatin-paclitaxel: effects on quality of life by Brotto, Lori, Brundage, Michael, Hoskins, Paul, Vergote, Ignace, Cervantes, Andres, Casado, Herraez A., Poveda, A., Eisenhauer, Elizabeth, Tu, Dongsheng

Get full text

Treatment guidelines in ovarian cancer by Poveda Velasco, A, Casado Herráez, A, Cervantes Ruipérez, A, Gallardo Rincón, D, García García, E, González Martín, A, López García, G, Mendiola Fernández, C, Ojeda González, B

Get full text

Time without symptoms or toxicity in patients with recurrent ovarian cancer receiving niraparib maintenance treatment versus placebo: A TWIST analysis of the ENGOT24-OV16/NOVA tria... by Matulonis, U.A., Walder, L., Nøttrup, T.J., Tinker, A.V., Mahner, S., Gil-Martin, M., Fabbro, M., Banerjee, S., Wenham, R.M., Woie, K., Gilbert, L., Harter, P., Herráez, A. Casado, Follana, P., Ledermann, J.A., Leroy, C., Scollo, P., Lund, B., Malander, S., Fisher, M., Guy, H., Mirza, M.R.

Get full text

Rucaparib maintenance treatment for recurrent ovarian carcinoma after response to platinum therapy (ARIEL3): a randomised, double-blind, placebo-controlled, phase 3 trial by Coleman, Robert L, Oza, Amit M, Lorusso, Domenica, Aghajanian, Carol, Oaknin, Ana, Dean, Andrew, Colombo, Nicoletta, Weberpals, Johanne I, Clamp, Andrew, Scambia, Giovanni, Leary, Alexandra, Holloway, Robert W, Gancedo, Margarita Amenedo, Fong, Peter C, O'Malley, David M, Armstrong, Deborah K, Garcia-Donas, Jesus, Swisher, Elizabeth M, Floquet, Anne, Konecny, Gottfried E, McNeish, Iain A, Scott, Clare L, Cameron, Terri, Maloney, Lara, Goble, Sandra, Grace, Caroline, Harding, Thomas C, Raponi, Mitch, Sun, James, Lin, Kevin K, Giordano, Heidi, Ledermann, Jonathan A, Buck, M, Dean, A, Friedlander, M L, Harnett, P, Scott, C L, Dirix, L, Vergote, I, Elit, L, Ghatage, P, Oza, A M, Plante, M, Provencher, D, Weberpals, J I, Floquet, A, Joly, F, Leary, A, Medioni, J, Tredan, O, You, B, El-Balat, A, Hänle, C, Krabisch, P, Neunhöffer, T, Pölcher, M, Wimberger, P, Amit, A, Kovel, S, Leviov, M, Safra, T, Shapira-Frommer, R, Stemmer, S, Bologna, A, Colombo, N, Lorusso, D, Sabbatini, R F, Scambia, G, Tamberi, S, Zamagni, C, Fong, P C, O'Donnell, A, Gancedo, M Amenedo, Garcia-Donas, J, Guerra, E M, Oaknin, A, Palacio, I, Romero, I, Sanchez, A, Banerjee, S N, Drew, Y, Jackson, D, Ledermann, J A, McNeish, I A, Parkinson, C, Powell, M, Buss, M K, Chambers, S K, Chen, L-m, Coleman, R L, Holloway, R W, Konecny, G E, Ma, L, Morgan, M A, Morris, R T, O'Malley, D M, Slomovitz, B M, Swisher, E M, Vanderkwaak, T, Vulfovich, M

Get full text

Pazopanib for metastatic soft-tissue sarcoma (PALETTE): a randomised, double-blind, placebo-controlled phase 3 trial by van der Graaf, Winette TA, Prof, Blay, Jean-Yves, Prof, Chawla, Sant P, MD, Kim, Dong-Wan, MD, Bui-Nguyen, Binh, MD, Casali, Paolo G, MD, Schöffski, Patrick, Prof, Aglietta, Massimo, MD, Staddon, Arthur P, MD, Beppu, Yasuo, MD, Le Cesne, Axel, MD, Gelderblom, Hans, Prof, Judson, Ian R, Prof, Araki, Nobuhito, MD, Ouali, Monia, MSc, Marreaud, Sandrine, MD, Hodge, Rachel, MSc, Dewji, Mohammed R, MSc, Coens, Corneel, MSc, Demetri, George D, MD, Fletcher, Christopher D, Prof, Dei Tos, Angelo Paolo, MD, Hohenberger, Peter, Prof

Get full text

OC-0271 First randomized study of Hafnium nanoparticles activated by radiotherapy in soft tissue sarcoma by Bonvalot, S., Rutkowski, P., Thariat, J., Carrere, S., Sunyach, M., Saada-Bouzid, E., Agoston, P., Hong, A., Mervoyer, A., Rastrelli, M., Le Pechoux, C., Moreno, V., Li, R., Tiangco, B., Herraez, A. Casado, Gronchi, A., Mangel, L., Hohenberger, P., Delannes, M., Papai, Z.

Get full text

82MO European multi-disciplinary tumor boards within the EURACAN network increasingly support management of patients with rare gynaecological tumors: 6-year activity results by Bergamini, A., Joneborg, U., Marquina, G., Grassi, E., Wallin, E., Herraez, A. Casado, Solheim, O., Sassu, C.M., Lok, C., Bini, M., Pautier, P., Kridelka, F., Sehouli, J., Van Nieuwenhuysen, E., Coulter, J., Bolze, P-A., Lebreton, C., Jurgen, P., Ray-Coquard, I.L., Seckl, M.J.

Get full text

17P Gynaecologic carcinosarcomas (GCS)’s chemotherapy landscape: A retrospective analysis from Hospital Clinico San Carlos (HCSC), academic, referral centre for rare gynaecological... by Diez, B.G., Herraez, A. Casado, Fernández, A. Manzano, Coronado, P., Santos, J. Garcia, Ramirez, M., Bellon, M., Del Hoyo, R. Sanchez, Pascual, A., Del Arco, C. Diaz, Sanmamed, N., Cerezo, E., Mendez, R., Muñoz, M., Espejo, J.M., Nava, A., Rodriguez, C., Ortega, A., Marquina, G.

Get full text

Efficacy and safety results from OCTAVIA, a single-arm phase II study evaluating front-line bevacizumab, carboplatin and weekly paclitaxel for ovarian cancer by Gonzalez-Martin, Antonio, Gladieff, Laurence, Tholander, Bengt, Stroyakovsky, Daniel, Gore, Martin, Scambia, Giovanni, Kovalenko, Nadezhda, Oaknin, Ana, Ronco, Julian Perez, Freudensprung, Ulrich, Pignata, Sandro

Get full text

PCN7 - A TIME WITHOUT SYMPTOMS OR TOXICITY ANALYSIS OF NIRAPARIB COMPARED WITH ROUTINE SURVEILLANCE IN THE MAINTENANCE TREATMENT OF PATIENTS WITH RECURRENT OVARIAN CANCER by Mirza, M.R., Walder, L., Monk, B.J., Tinker, A.V., Mahner, S., Gil-Martin, M., Kalbacher, E., Waters, J., Wenham, R.M., Malander, S., Gilbert, L., Sehouli, J., Casado Herraez, A., Hardy-Bessard, A., Williams, S.J., Rimel, B.J., Lund, B., Levy, T., Guy, H., Matulonis, U.A.

Get full text

Epidermal Growth Factor Receptor (EGFR) Pathway Biomarkers in the Randomized Phase III Trial of Erlotinib Versus Observation in Ovarian Cancer Patients with No Evidence of Disease... by Despierre, Evelyn, Vergote, Ignace, Anderson, Ryan, Coens, Corneel, Katsaros, Dionyssios, Hirsch, Fred R., Boeckx, Bram, Varella-Garcia, Marileila, Ferrero, Annamaria, Ray-Coquard, Isabelle, Berns, Els M. J. J., Casado, Antonio, Lambrechts, Diether, Jimeno, Antonio

Get full text

Trebananib or placebo plus carboplatin and paclitaxel as first-line treatment for advanced ovarian cancer (TRINOVA-3/ENGOT-ov2/GOG-3001): a randomised, double-blind, phase 3 trial by Wenham, Robert M, Pickett, Cheryl A, Park, Sang Yoon, Makarova, Yulia, Krikunova, Ludmila, Bae, Duk-Soo, Zamagni, Claudio, Tognon, Germana, Ortega, Eugenia, Green, Andrew, Burger, Robert, Sanchez, Andres Redondo, Peen, Ulla, Kamelle, Scott, Carney, Michael, Forget, Frédéric, Bentley, James, Sehouli, Jalid, Kato, Hidenori, Shahin, Mark, Bhoola, Snehalkumar, Anderson, Daniel, Pelgrims, Joseph (Gino), Hansen, Vincent, Van den Bulck, Heidi, Yokota, Harushige, Friedman, Richard, Covens, Allan, Hilpert, Felix, Savarese, Antonella, Pignata, Sandro, Teneriello, Michael, Lentz, Samuel, Mannel, Robert, Lim, Peter, Zorr, Andreas, Karck, Ulrich, Aoki, Daisuke, Hirashima, Yasuyuki, Boere, Ingrid, Braly, Patricia, Schilder, Jeanne, Secord, Angeles, Rojas-Espaillat, Luis, Schauer, Christian, Joosens, Eric, Burges, Alexander, Park-Simon, Tjoung-Won, Alabiso, Oscar, Sawasaki, Takashi, Ibañez, Ana Herrero, Spillman, Monique, Moore, David, Verhoeven, Didier, Schnappauf, Benjamin, Schmalzrie, Hannah, Kalofonos, Haralambos, Diaz, Cristina Caballero, Polo, Susana Hernando, Garrison, Mitchell, Basil, Jack, Cosin, Jonathan, Wade III, James, Buekers, Thomas, DAndre, Stacy, Bakkum-Gamez, Jamie, Van Le, Linda, Puls, Larry, Michelson, Elizabeth Dickson, Kerger, Joseph, Heubner, Martin, Lordick, Florian, Villanueva, William Orlando Brito, Kessels, Lonneke, Fabregat, Miguel Beltran, Kumar, Pallavi, Karimi, Misagh, Edraki, Babak, Morris, Robert, Method, Michael, Drake, Janet, Wadsworth, Troy, Hurteau, Jean, Malad, Salman, Robinson-Bennett, Bernice, Davidson, Susan, Gaur, Rakesh, Krasner, Carolyn, Ueland, Frederick, Talmage, Lance, Sutton, Gregory, Osborne, Janet, Williams, James, Fleming, Nicole, Herzog, Thomas, Leitao, Mario, Mendez, Luis, Patel, Dhimant, Spitzer, Gary, Miller, Brigitte

Get full text

Cardiac metastasis from uterine leiomyosarcoma by Moreno Antón, F, Casado Herraez, A, Puente Vázquez, J, Gómez Díaz, R, Aragoncillo, P, Díaz-Rubio García, E

Get full text

Vimseltinib versus placebo for tenosynovial giant cell tumour (MOTION): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial by Gelderblom, Hans, Bhadri, Vivek, Stacchiotti, Silvia, Bauer, Sebastian, Wagner, Andrew J, van de Sande, Michiel, Bernthal, Nicholas M, López Pousa, Antonio, Razak, Albiruni Abdul, Italiano, Antoine, Ahmed, Mahbubl, Le Cesne, Axel, Tinoco, Gabriel, Boye, Kjetil, Martín-Broto, Javier, Palmerini, Emanuela, Tafuto, Salvatore, Pratap, Sarah, Powers, Benjamin C, Reichardt, Peter, Casado Herráez, Antonio, Rutkowski, Piotr, Tait, Christopher, Zarins, Fiona, Harrow, Brooke, Sharma, Maitreyi G, Ruiz-Soto, Rodrigo, Sherman, Matthew L, Blay, Jean-Yves, Tap, William D, Loong, Herbert, Brunello, Antonella, Krieg, Andreas, Algulnik, Mark, Riedel, Richard, Okuno, Scott, Loggers, Elizabeth, Alcindor, Thierry, Ferraresi, Virginia, Serrano, César, Randall, R. Lor, Wilky, Breelyn, Ravi, Vinod

Get full text

Phase II trial of ifosfamide in combination with the VEGFR inhibitor sorafenib in advanced soft tissue sarcoma: a Spanish group for research on sarcomas (GEIS) study by García del Muro, Xavier, Maurel, Joan, Martínez Trufero, Javier, Lavernia, Javier, López Pousa, Antonio, de las Peñas, Ramón, Cubedo, Ricardo, Berros, José Pablo, Casado Herráez, Antonio, de Juan, Ana, Martín Broto, Javier

Get full text

NBTXR3, a first-in-class radioenhancer hafnium oxide nanoparticle, plus radiotherapy versus radiotherapy alone in patients with locally advanced soft-tissue sarcoma (Act.In.Sarc):... by Bonvalot, Sylvie, PhD, Rutkowski, Piotr L, Prof, Thariat, Juliette, Prof, Carrère, Sébastien, MD, Ducassou, Anne, MD, Sunyach, Marie-Pierre, MD, Agoston, Peter, MD, Hong, Angela, MBBS, Mervoyer, Augustin, MD, Rastrelli, Marco, MD, Moreno, Victor, MD, Li, Rubi K, MD, Tiangco, Béatrice, MD, Herraez, Antonio Casado, MD, Gronchi, Alessandro, MD, Mangel, László, MD, Sy-Ortin, Teresa, MD, Hohenberger, Peter, Prof, de Baère, Thierry, Prof, Le Cesne, Axel, MD, Helfre, Sylvie, MD, Saada-Bouzid, Esma, MD, Borkowska, Aneta, MD, Anghel, Rodica, MD, Co, Ann, MD, Gebhart, Michael, Prof, Kantor, Guy, Prof, Montero, Angel, MD, Loong, Herbert H, MD, Vergés, Ramona, MD, Lapeire, Lore, MD, Dema, Sorin, MD, Kacso, Gabriel, MD, Austen, Lyn, MD, Moureau-Zabotto, Laurence, MD, Servois, Vincent, MD, Wardelmann, Eva, Prof, Terrier, Philippe, MD, Lazar, Alexander J, MD, Bovée, Judith V M G, Prof, Le Péchoux, Cécile, MD, Papai, Zsusanna, Prof

Get full text

Characterization and Management of Adverse Reactions in Patients with Advanced Endometrial Carcinoma Treated with Lenvatinib Plus Pembrolizumab by Makker, Vicky, Taylor, Matthew H., Oaknin, Ana, Casado Herraez, Antonio, Orlowski, Robert, Dutta, Lea, Ren, Min, Zale, Melissa, O'Malley, David M.

Get full text